EUVIMEDEUVIMED entdecken
Crossref

Ligand-Based Computational Design and Preclinical Evaluation of a Novel Cyclic Peptide Radiotracer for FGFR1-Targeted PET Imaging in Uveal Melanoma

Ling Wang, Xue Zhu iD, Mengxi Yu, Hong Zhu, Zhihong Huang, Yan Xue, Shuang Wang, Yang Jiao, Yonghao Li, Bin Lian, Chunwei Xu, Yue Hao und 2 weitere

ACS Sensors · 2026

DOI: 10.1021/acssensors.5c04161 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Sensors, 2026. Verfasst von Ling Wang und 13 weiteren Autor:innen. Beteiligte Einrichtung: National Health Commission Key Laboratory of Nuclear Medicine, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Med…. Hauptthemen laut MEDLINE: Melanoma, Uveal Neoplasms, Peptides, Cyclic, Receptor, Fibroblast Growth Factor, Type 1. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Wuxi Science and Technology Association, Basic Research Program of Jiangsu Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaUveal NeoplasmsPeptides, CyclicReceptor, Fibroblast Growth Factor, Type 1Positron-Emission TomographyRadiopharmaceuticalsHumansAnimalsUveal MelanomaLigandsMiceCell Line, TumorGallium RadioisotopesDrug Design

Stichwörter der Autor:innen

FGFR1[68Ga]Ga-DOTA-cHW8cyclic peptidemicroPET imaginguveal melanoma

Substanzen

Peptides, CyclicReceptor, Fibroblast Growth Factor, Type 1LigandsFGFR1 protein, humanGallium RadioisotopesRadiopharmaceuticals

Autor:innen und Institutionen

  • National Health Commission Key Laboratory of Nuclear Medicine, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi 214063, China.
  • Department of Radiopharmaceuticals, School of Pharmacy, Nanjing Medical University, Nanjing 211166, China.
  • Department of Pharmacy, Suzhou Guangji Hospital, The Affiliated Guangji Hospital of Soochow University, Suzhou 215137, China.
  • Department of Ophthalmology, Wuxi No. 2 People's Hospital, Jiangnan University Medical Center (JUMC), Wuxi 214000, China.
  • Institute of Pharmacology & Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
  • Innovation Institute for Artificial Intelligence in Medicine, Zhejiang University, Hangzhou 310015, China.

ORCID-Profile: Xue Zhu, Jing Fang, Ke Wang

Förderung

  • Wuxi Science and Technology Association
  • Basic Research Program of Jiangsu Province
  • National Natural Science Foundation of China
  • Jiangsu Commission of Health
  • Jiangsu Provincial Medical Key Discipline Laboratory
  • Wuxi Science and Technology Development Foundation
  • Wuxi Municipal Health Commission

Zitieren

APA

Wang, L., Zhu, X., Yu, M., Zhu, H., Huang, Z., Xue, Y., Wang, S., Jiao, Y., Li, Y., Lian, B., Xu, C., Hao, Y., Fang, J., & Wang, K. (2026). Ligand-Based Computational Design and Preclinical Evaluation of a Novel Cyclic Peptide Radiotracer for FGFR1-Targeted PET Imaging in Uveal Melanoma. ACS Sensors. https://doi.org/10.1021/acssensors.5c04161

Vancouver

Wang L, Zhu X, Yu M, Zhu H, Huang Z, Xue Y, et al. Ligand-Based Computational Design and Preclinical Evaluation of a Novel Cyclic Peptide Radiotracer for FGFR1-Targeted PET Imaging in Uveal Melanoma. ACS Sensors. 2026. doi:10.1021/acssensors.5c04161

BibTeX
@article{Wang2026,
  author = {Wang, Ling and Zhu, Xue and Yu, Mengxi and Zhu, Hong and Huang, Zhihong and Xue, Yan and Wang, Shuang and Jiao, Yang and Li, Yonghao and Lian, Bin and Xu, Chunwei and Hao, Yue and Fang, Jing and Wang, Ke},
  title = {Ligand-Based Computational Design and Preclinical Evaluation of a Novel Cyclic Peptide Radiotracer for FGFR1-Targeted PET Imaging in Uveal Melanoma},
  journal = {ACS Sensors},
  year = {2026},
  doi = {10.1021/acssensors.5c04161}
}
Kostenlos starten →